Table 2.
Symptomatic patient (n = 112) | Asymptomatic patient (n = 27) | p value | ||
---|---|---|---|---|
Culprit (n = 112) | Contralateral non-culprit (n = 26) | |||
TOF-stenosis, median [IQR] (%) | 67.3 [54.1, 80.5] | 48.8 [32.4, 72.3] | 55.3 [47.0, 72.6] | 0.002 |
No stenosis (<29 %), n (%) | 2 (1.8) | 5 (19.2) | 3 (11.1) | 0.003 |
Mild (30-49 %), n (%) | 18 (16.1) | 8 (30.8) | 5 (18.5) | 0.278 |
Moderate (50–69 %), n (%) | 40 (35.7) | 5 (19.2) | 12 (44.4) | 0.777 |
Severe (70–99 %), n (%) | 25 (22.3) | 5 (19.2) | 4 (14.8) | 0.558 |
Occlusion, n (%) | 27 (24.1) | 3 (11.6) | 3 (11.1) | 0.088 |
Plaque burden (%) | 91 [84, 96] | 75 [66, 88] | 83 [74, 89] | <0.0001 |
Minimum luminal area (mm2) | 0.95 [0.43, 1.94] | 3.12 [1.66, 5.06] | 2.22 [1.08, 3.15] | <0.0001 |
Plaque volume (mm3) | 45.27 [23.93, 61.80] | 27.82 [19.20, 44.29] | 29.35 [21.14, 43.20] | 0.020 |
Plaque length (mm) | 8 [6, 12] | 6 [4, 9.5] | 8 [4, 8] | 0.002 |
Normalized T1 signal intensity >1.0, n (%) | 7 (6.3) | 0 (0) | 1 (3.7) | 0.439 |
Normalized T2 signal intensity >1.0, n (%) | 27 (24.1) | 4 (15.4) | 8 (29.6) | 0.953 |
Normalized CE-T1 signal intensity >1.0, n (%) | 54 (48.2) | 2 (7.7) | 7 (25.9) | 0.0002 |